Release Date: 09/12/21 09:43 Summary: Acquisition of Properties, Placement and Guidance Upgrade Price Sensitive: Yes Download Document 199.13KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status